PDE8B
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B
Also known as: PDE8B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95263
- Gene
- PDE8B
- Ensembl
- ENSG00000113231
- Chromosome
- 5
- Canonical length
- 885 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a cyclic nucleotide phosphodiesterase (PDE) that catalyzes the hydrolysis of the second messenger cAMP. The encoded protein, which does not hydrolyze cGMP, is resistant to several PDE inhibitors. Defects in this gene are a cause of autosomal dominant striatal degeneration (ADSD). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
885 residues, UniProt reviewed canonical sequence.
>O95263|PDE8B
1 MGCAPSIHVS QSGVIYCRDS DESSSPRQTT SVSQGPAAPL PGLFVQTDAA DAIPPSRASG
61 PPSVARVRRA RTELGSGSSA GSAAPAATTS RGRRRHCCSS AEAETQTCYT SVKQVSSAEV
121 RIGPMRLTQD PIQVLLIFAK EDSQSDGFWW ACDRAGYRCN IARTPESALE CFLDKHHEII
181 VIDHRQTQNF DAEAVCRSIR ATNPSEHTVI LAVVSRVSDD HEEASVLPLL HAGFNRRFME
241 NSSIIACYNE LIQIEHGEVR SQFKLRACNS VFTALDHCHE AIEITSDDHV IQYVNPAFER
301 MMGYHKGELL GKELADLPKS DKNRADLLDT INTCIKKGKE WQGVYYARRK SGDSIQQHVK
361 ITPVIGQGGK IRHFVSLKKL CCTTDNNKQI HKIHRDSGDN SQTEPHSFRY KNRRKESIDV
421 KSISSRGSDA PSLQNRRYPS MARIHSMTIE APITKVINII NAAQENSPVT VAEALDRVLE
481 ILRTTELYSP QLGTKDEDPH TSDLVGGLMT DGLRRLSGNE YVFTKNVHQS HSHLAMPITI
541 NDVPPCISQL LDNEESWDFN IFELEAITHK RPLVYLGLKV FSRFGVCEFL NCSETTLRAW
601 FQVIEANYHS SNAYHNSTHA ADVLHATAFF LGKERVKGSL DQLDEVAALI AATVHDVDHP
661 GRTNSFLCNA GSELAVLYND TAVLESHHTA LAFQLTVKDT KCNIFKNIDR NHYRTLRQAI
721 IDMVLATEMT KHFEHVNKFV NSINKPMAAE IEGSDCECNP AGKNFPENQI LIKRMMIKCA
781 DVANPCRPLD LCIEWAGRIS EEYFAQTDEE KRQGLPVVMP VFDRNTCSIP KSQISFIDYF
841 ITDMFDAWDA FAHLPALMQH LADNYKHWKT LDDLKCKSLR LPSDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE8B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 117 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 117 nTPM
- cerebral cortex: 26 nTPM
- fallopian tube: 26 nTPM
- blood vessel: 25 nTPM
- hypothalamus: 24 nTPM
- basal ganglia: 24 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 344 nCPM
- brain inhibitory neurons: 248 nCPM
- other brain neurons: 225 nCPM
- brain excitatory neurons: 147 nCPM
- pericytes: 94 nCPM
- astrocytes: 85 nCPM
Immune cell
- intermediate monocyte: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
- eosinophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hypothalamus: 89 nTPM
- basal ganglia: 71 nTPM
- hippocampal formation: 65 nTPM
- cerebral cortex: 63 nTPM
- amygdala: 62 nTPM
- medulla oblongata: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDE8B.
Disease | AllUniProt
Conditions PDE8B is implicated in, by any mechanism.
- Striatal degeneration, autosomal dominant 1 (ADSD1) MIM:609161
- Primary pigmented nodular adrenocortical disease 3 (PPNAD3) MIM:614190
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 356 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant striatal neurodegeneration type 1
- Pigmented nodular adrenocortical disease, primary, 3
- Inborn genetic diseases
- PDE8B-Related Disorders
Disease | ImmuneIEDB
Conditions an epitope on PDE8B was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 3
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- behavioral fear response
- cAMP catabolic process
- negative regulation of cAMP/PKA signal transduction
- negative regulation of insulin secretion involved in cellular response to glucose stimulus
- neuromuscular process controlling balance
- operant conditioning
- positive regulation of ERK1 and ERK2 cascade
- signal transduction
- visual learning
- negative regulation of steroid hormone biosynthetic process
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PAS domain
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- HD/PDEase domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- PAS domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- PDE8-like, REC N-terminal domain
- 3'5'-cyclic nucleotide phosphodiesterase
- PDE8 phosphodiesterase
- PAS domain
- PDE8A-like, N-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE8B as an antibody target. Whether an autoantibody or antibody against PDE8B could matter depends on whether native PDE8B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE8B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE8B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...